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without patient harmRianne J. Zaal1*, Jasperien E. van Doormaal2, Albert W. Lenderink3, Peter G. M. Mol4,
Jos G.W. Kosterink2, Toine C. G. Egberts5,6, Flora M. Haaijer-Ruskamp4 and
Patricia M. L. A. van den Bemt5,7
1Department of Clinical Pharmacy, TweeSteden hospital and St. Elisabeth Hospital, Tilburg, the Netherlands
2Department of Hospital and Clinical Pharmacy, University of Groningen and University Medical Center Groningen, Groningen, the
Netherlands
3All care 4 IT, Loon op Zand, the Netherlands
4Department of Clinical Pharmacology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands
5Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science,
Utrecht University, Utrecht, The Netherlands
6Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands
7Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the NetherlandsSUMMARY
Purpose To compare determinants for medication errors leading to patient harm with determinants for medication errors without patient harm.
Methods A two-way case-control design was used to identify determinants for medication errors without harm (substudy 1) and determinants for
medication errors causing harm (substudy 2). Data of patients admitted to five internal medicinewards of twoDutch hospitals during 5months were
collected prospectively by chart review. Medication errors were detected and classified by two pharmacists. Consensus between five pharmacists
was reached on the causal relationship betweenmedication errors and patient harm. Data analysis was performed bymultivariate logistic regression.
Results We included 7286 medication orders, of which 3315 without errors (controls), and 5622 medication errors without harm (cases
substudy 1) and 102 medication errors causing harm (cases substudy 2) were identified. Hospital, ward and the therapeutic class anti-
infectives were associated with both medication errors without harm (hospital odds ratio (OR) 1.40; 95% confidence interval (CI) 1.21–1.63),
TweeSteden hospital (TSh) geriatrics OR 2.03; 95% CI 1.73–2.38, TSh general internal medicine OR 1.44; 95% CI 1.23–1.69 and anti-
infectives OR 1.28; 95% CI 1.06–1.56) and medication errors with harm (hospital OR 4.91; 95% CI 3.02–7.79, TSh geriatrics OR 5.76; 95%
CI 2.52–13.15, TSh general internal medicine OR 6.51; 95% CI 2.82–15.02 and anti-infectives OR 4.20; 95% CI 2.24–7.90).
Conclusions This study shows that organisational determinants (hospital, ward) are comparable for medication errors with and without harm. For
conclusions on patient- andmedication-related determinants studies with larger sample sizes are needed. Copyright# 2010 JohnWiley& Sons, Ltd.key words—medication errors; preventable adverse drug events; medication safety; hospitalised patients; determinants; pharmacoepidemiology
Received 28 July 2009; Revised 26 March 2010; Accepted 1 April 2010INTRODUCTION toxicity of the drug and the susceptibility of the patientThe prevalence of medication errors in hospitals is
about 6% of all medication orders and approximately
10% of all medication errors is estimated to result in
patient harm.1 Whether or not a medication error
results in patient harm depends on whether the error
reaches the patient and when it does, on the intrinsic*Correspondence to: R. J. Zaal, Department of clinical pharmacy, TweeS-
teden hospital, PO Box 90 107, 5000 LA Tilburg, The Netherlands.
E-mail: rzaal@tsz.nl
Copyright # 2010 John Wiley & Sons, Ltd.to adverse events. Also, certain types of medication
errors are more likely to cause patient harm than others,
e.g. therapeutic prescribing errors result in harm more
often than administrative prescribing errors do.2–5
Despite the fact that not all medication errors lead to
patient harm, the impact of the problem of adverse drug
events (ADEs) induced by such errors is rather large.
The report ‘To err is human’ showed that in the United
States 2% of all admitted patients is harmed as a result
of a medication error and that 7000 patients die from
medication errors annually.6 This report has led to a
826 r. j. zaal ET AL.renewed interest of health care professionals in
improving medication safety. Such improvements
can be achieved by effective interventions targeted
at identified risk factors that contribute to unsafe
practices and potential patient harm.
Whereas preventing actual patient harm is the
ultimate goal of such medication safety initiatives,
medication errors are often used as a surrogate
outcomemeasure, because these occur more frequently
and are easier to detect. However, the validity of this
surrogate end point has not been established and it is
unknown whether the risk factors associated with
medication errors causing patient harm are the same
as the risk factors associated with medication errors
that do not cause harm. Therefore, we performed a
study to compare the determinants for medication
errors resulting in patient harm and the determinants
for medication errors not resulting in harm.
METHODS
Design and setting
The design of the current study is a two-way case-
control study. In a first substudy (first way), medication
orders with errors not leading to patient harm (cases)
were compared to medication orders without errors
(controls). This first substudy aimed to identify
determinants for medication errors not leading to
patient harm. In the second substudy (second way)
medication orders with errors leading to patient harm
(cases) were again compared to the same medication
orders without errors (controls) to identify determi-
nants for medication errors leading to patient harm.
Subsequently, determinants that were identified in
the first substudy were compared with determinants
identified in the second substudy.
This study is a part of the Physician Order Entry and
Medication Safety (POEMS) study on the effect of a
computerised physician order entry (CPOE) system on
Medication Safety and associated costs.5,7,8 The
POEMS study is a prospective intervention study,
performed in two medical wards (one geriatric and one
general internal medicine ward) of the 600 bed
teaching hospital ‘TweeSteden’ (TSh) in Tilburg and
Waalwijk and three medical wards (two general
internal medicine wards and one gastroenterology/
rheumatology ward) of the 1300 bed University
Medical Center in Groningen (UMCG), the Nether-
lands. The current study uses data of the period before
the introduction of the CPOE system. The process of
medication ordering and administration consisted of a
hand-written system: physicians prescribed medicationCopyright # 2010 John Wiley & Sons, Ltd.orders on charts and nurses transcribed these medi-
cation orders on administration charts. Therefore,
clinical decision support could not be provided to
physicians at the time of prescribing medication.
Patients
From July through November 2005 all patients
admitted to the study wards for more than 24 hours
were included. Patients received written information
about the study after which they could object to
inclusion. Awaiver of the Medical Ethical Committee
was obtained for this study, as the study fell within the
boundaries of normal hospital care and routine of
quality improvement and assurance.
Data collection
During ward visits the investigators prospectively
extracted patients’ characteristics (age, sex, weight and
length) and data on diseases (medical history, reasons
for admission and diagnoses) and adverse events (i.e.
untoward medical occurrences which do not have to
have a causal relationship with the treatment9) from
medical records. Medication orders issued during
hospitalisation were collected by reviewing medication
order charts and administration charts. For ethical
reasons, the physician was informed in case of
potentially life threatening errors that were discovered
during the process of data collection. These errors were
not excluded from the study.
Classification of prescribing and transcribing
errors
Medication errors were identified and categorised by
two pharmacists according to the classification scheme
for medication errors developed by the Dutch
Association of Hospital Pharmacists.10 During a pilot
phase in the UMCG, two pharmacists were trained
together to extract and classify medication errors
uniformly. The classification distinguishes prescribing,
transcribing, dispensing, administering and ‘across
settings’ errors. In this study only prescribing and
transcribing errors were recorded. Prescribing errors
are subdivided into administrative errors (errors on
readability, patient data, ward and prescriber data, drug
name, dosage form and route of administration), dosing
errors (errors on strength, frequency, dosage, length of
therapy and directions for use) and therapeutic errors
(interactions, contra-indications, incorrect mono-
therapy, duplicate therapy and errors on therapeutic
drug monitoring or laboratory monitoring). Inappropri-Pharmacoepidemiology and Drug Safety, 2010; 19: 825–833
DOI: 10.1002/pds
determinants for medication errors 827ate drug choices were not actively assessed and were
only taken into account when they were obvious.
Transcribing errors are defined as errors in the process
of interpreting, verifying and transcribing medication
errors. The severity of all medication errors was
assessed according to the index of the National
Coordinating Council for Medication Error Reporting
and Preventing (NCC MERP), which categorises
medication errors into nine categories (A–I) based
on severity of related patient outcomes (Table 1).11 In
this study, medication errors were divided into errors
that did not lead to patient harm (NCCMERP category
B up to D) and errors that did lead to harm (NCC
MERP category E up to I).
Patient harm
Patient harm was defined as a preventable adverse drug
event (pADE) which is an adverse drug event (ADE)
that occurred due to a medication error with a possible
or probable causal relationship with the medication
error. To assess this relationship an algorithm was
developed, based on the NCC MERP index and the
Yale algorithm.7,11,12 Our combined algorithm was
described in detail and validated in a previous
publication.7 The Yale algorithm (Table 2) assesses
the causality of the association between a drug and an
adverse event. In our algorithm the first three items of
the Yale algorithm were used: knowledge about the
relation between the drug and the event, the presence of
underlying clinical conditions which could be respon-
sible for the event and the timing of the event. The
causal relations between all medication errors made
and the adverse events extracted from the medical
records were assessed by five pharmacists. After
individual assessment, consensus was reached for all
cases on both causality and severity. The causal
relationship could be defined as unlikely (score< 0),
possible (score 0 and 3) or probable (score¼ 4).




Circumstances or events that have the capacity
B An error occurred but the error did not reach t
C An error occurred that reached the patient but
D An error occurred that reached the patient and
and/or required intervention to preclude harm
E
Patient harm
An error occurred that may have contributed t
F An error occurred that may have contributed t
prolonged hospitalisation
G An error occurred that may have contributed t
H An error occurred that required intervention ne
I An error occurred that may have contributed t
Copyright # 2010 John Wiley & Sons, Ltd.was reached on a possible or probable relationship with
the medication error. Earlier we described the
interobserver reliability on the presence of a pre-
ventable ADE and the severity of the preventable ADE
assessed with the combined algorithm.7
Determinants
Determinants for medication errors or (preventable)
ADEs that were identified in previous studies were
included, provided that the data could be extracted
from medical records or medication orders.1–4,13–23
Potential determinants of medication errors with and
without patient harm that were studied were organis-
ational characteristics (hospital, ward, transfer from
another hospital ward or care institution, length of stay
and readmission to study ward during study period),
patient characteristics (gender, age, renal impairment
(defined as creatinine clearance 50ml/minute during
hospitalisation) and the number of medication orders
per patient during hospital stay), characteristics of the
medication order (weekday of prescription, dosage
frequency less than once daily and route of adminis-




All data were processed with MS Access 2003 and
analysed with SPSS version 16.0.
Determinants for medication errors that did not
lead to patient harm were identified by comparing
medication orders containing these errors with
medication orders without errors (substudy 1). Deter-
minants for medication errors that resulted in patient
harm were identified by comparing medication orders
containing these errors with medication orders without
errors (substudy 2). Univariate logistic regression
analysis was performed with the medication order asto cause error
he patient
did not cause patient harm
required monitoring to confirm that it resulted in no harm to the patient
o or resulted in temporary harm to the patient and required intervention
o or resulted in temporary harm to the patient and required initial or
o or resulted in permanent patient harm
cessary to sustain life
o or resulted in the patient’s death
Pharmacoepidemiology and Drug Safety, 2010; 19: 825–833
DOI: 10.1002/pds
Table 2. Simplified Yale algorithm12
þ1 0 1
Axis 1 Adverse event is well accepted as ADR to suspected drug. Adverse event is not well known
or drug is new.
Adverse event previously unreported
as ADR to well-known drug.
Axis 2 (a) No good alternative candidate (score þ2)
(b) Otherwise unexplained exacerbation or recurrence
of underlying illness (score þ1)
Alternative candidate(s) exist,
but no good ones.
Good alternative candidate.
Axis 3 Timing as expected for ADR for this adverse
event-drug pair.
Timing equivocal or non-assessable Timing inconsistent for ADR for this
adverse event-drug pair (score 2)
Total score
Score< 0: ADR is unlikely
Score 0 andþ3: ADR is possible.
Score¼ 4: ADR is probable
Abbreviations: ADR, adverse drug reaction.
Figure 1. Patient characteristics, medication orders and medication errors
828 r. j. zaal ET AL.unit of analysis. Multiple errors could have been made
in one medication order and analysis was performed
for each medication error separately.
For determinants that were statistically significantly
associated (p< 0.05) with errors in the univariate
analysis, a multivariable logistic regression analysis
was performed using a manual stepwise forward
logistic regression model. Determinants were con-
secutively entered into the model and when they
changed the b coefficient with at least 10%, their
contribution was considered relevant and the determi-
nant remained in the model. Crude and adjusted odds
ratios (ORs) with 95% confidence intervals (CIs) were
calculated. Determinants that were significantly
associated with medication errors without harm in
substudy 1 were compared to determinants for
medication errors leading to patient harm identified
in substudy 2.
RESULTS
During data collection 558 patients were included
and four patients were excluded from the study due to
objection to inclusion. Since 28 patients were re-
admitted once and three patients were re-admitted twice,
592 admissions were included in the study. During these
admissions, 7286 medication orders were prescribed of
which 3315 contained no error (controls). In the other
3971medication orders a total of 5724medication errors
were identified of which 5622 did not cause patient harm
(cases substudy 1) and 102 resulted in patient harm
(cases substudy 2) (Figure 1). Nine medication errors
were considered serious enough to require an interven-
tion by the investigators to preclude harm. These errors
were classified as errors that did not result in patient
harm, but which required interventions to preclude harm
(NCC MERP category D).Copyright # 2010 John Wiley & Sons, Ltd.Details of the univariate and multivariate analysis of
organisational characteristics, patient characteristics,
characteristics of the medication order and the
therapeutic area are presented in Tables 3–6.
After multivariate analysis, the following determi-
nants were significantly associated with medication
errors without patient harm: hospital, ward, transfer of
patient, length of hospital stay, number of medication
orders per patient during hospital stay, weekday of
the prescription, route of administration and the
therapeutic classes cardiovascular tract, genitourinary
system and hormonal system, hormonal systemic
therapy, anti-infectives, musculoskeletal system, ner-
vous system and respiratory tract.
Of these determinants the following were also
statistically significantly associated with medication
errors with harm: hospital, ward and therapeutic class
anti-infectives.Pharmacoepidemiology and Drug Safety, 2010; 19: 825–833
DOI: 10.1002/pds
Table 3. Organisational characteristics associated with medication errors with and without patient harm after univariate logistic regression (odds ratios) and
multivariate logistic regression (adjusted odds ratios)





OR 95% CI ORadj 95% CI Cases
n (%)
OR 95% CI ORadj 95% CI
Hospital
TSh (UMCG is reference) 1459 (44.0) 3468 (61.7) 2.05 1.88–2.24 1.40 1.21–1.63 81 (79.4) 4.91 3.02–7.97 4.91y 3.02–7.97
Ward
UMCG general internal medicine 732 (22.1) 904 (16.1) ref ref 7 (6.9) ref ref
UMCG gastroenterology/rheumatology 1124 (33.9) 1250 (22.2) 0.90 0.79–1.02 0.93z 0.79–1.08 14 (13.7) 1.30 0.52–3.24 1.73x 0.68–4.41
TSh geriatrics 796 (24.0) 2250 (40.0) 2.29 2.02–2.60 2.03z 1.73–2.38 49 (48.0) 6.44 2.90–14.30 5.76x 2.52–13.15
TSh general internal medicine 663 (20.0) 1218 (21.7) 1.49 1.30–1.70 1.44z 1.23–1.69 32 (31.4) 5.05 2.21–11.51 6.51x 2.82–15.02
Transfer from: (n¼ 8255/n¼ 3056)
Home (ref) 1566 (52.7) 3175 (60.1) ref ref 56 (59.6) ref
Another hospital ward 254 (8.5) 446 (8.4) 0.87 0.73–1.02 0.68 0.58–0.81 9 (9.6) 0.99 0.48–2.02
Care institution 1151 (38.7) 1663 (31.5) 0.71 0.65–0.79 0.86 0.78–0.96 29 (30.9) 0.71 0.45–1.11
Length of stay (days, mean SD) 19.2 15.5 22.2 17.0 1.01 1.01–1.02 1.02jj 1.01–1.02 20.4 11.7 1.00 0.99–1.02
Readmission 233 (7.0) 360 (6.4) 0.91 0.76–1.07 8 (7.8) 1.13 0.54–2.35
Figures in bold are statistically significant
Abbreviations: OR, odds ratio; 95%CI, 95% confidence interval; ORadj, adjusted odds ratio; TSh, TweeSteden hospital; UMCG, University Medical Center
Groningen; ref, reference
Ward, transfer and day of prescription contributed significantly to the model
yNo confounding factors were identified
zTransfer, length of stay, age group, renal impairment, number of medication orders, day of prescription, and pharmacotherapeutic area contributed significantly
to the model
xAge and pharmacotherapeutic area contributed significantly to the model
Hospital, ward and length of stay contributed significantly to the model
jjNumber of medication orders contributed significantly to the model.
Analysed as a continuous variable
Table 4. Patient characteristics associated with medication errors with and without patient harm after univariate logistic regression (odds ratios) and
multivariate logistic regression (adjusted odds ratios)
Medication errors without harm (substudy 1) Medication errors with harm (substudy 2)
Potential determinant Controls
n (%)
Cases n (%) OR 95% CI ORadj 95% CI Cases n (%) OR 95% CI ORadj 95% CI
Female gender
(male is reference)
1780 (53.7) 2990 (53.2) 0.98 0.90–1.07 47 (46.1) 0.74 0.50–1.10
Age (years, meanSD) 67.1 17.8 70.8 16.8 1.01 1.01–1.02 1.00 1.00–1.01 74.1 14.8 1.03 1.01–1.04 1.01y 1.00–1.03
<50 years 605 (18.3) 778 (13.8) ref ref 9 (8.8) ref ref
50 to 64 years 668 (20.2) 882 (15.7) 1.03 0.89–1.19 1.00z 0.85–1.18 12 (11.8) 1.21 0.51–2.89 1.35x 0.56–3.26
65 to 79 years 1053 (31.8) 1859 (33.1) 1.38 1.21–1.56 0.99z 0.84–1.17 38 (37.3) 2.43 1.17–5.05 1.77x 0.81–3.90
 80 years 989 (29.8) 2103 (37.4) 1.65 1.45–1.88 1.02z 0.85–1.23 43 (42.2) 2.92 1.42–6.04 1.74x 0.76–4.02
Renal impairment 1700 (51.3) 3176 (56.5) 1.23 1.13–1.34 1.03 0.92–1.16 61 (59.8) 1.41 0.95–2.11
Number of medication
orders (meanSD)
18.2 10.7 19.2 17.0 1.01 1.00–1.01 0.99jj 0.99–1.00 18.3 9.1 1.00 0.98–1.02
Polypharmacy (>4) 3253 (98.1)# 5534 (98.4) 1.20 0.86–1.66 103 (99.0)# 1.99 0.27–14.52
Figures in bold are statistically significant.
Abbreviations: OR, odds ratio; 95%CI, 95% confidence interval; ORadj, adjusted odds ratio.Hospital, ward, length of stay and pharmacotherapeutic area contributed significantly to the model.
yHospital contributed significantly to the model.
zHospital, ward, transfer, length of stay, renal impairment, number of medication orders, day of prescription, route of administration and pharmacotherapeutic
area contributed significantly to the model.
xHospital, ward and pharmacotherapeutic area contributed significantly to the model.
Hospital, ward, transfer, length of stay, age, number of medication orders, day of prescription, route of administration and pharmacotherapeutic area
contributed significantly to the model.
jjHospital, ward, transfer, length of stay, day of prescription, route of administration and pharmacotherapeutic area contributed significantly to the model.
Analysed as a continuous variable.
#Dummy variables included.
Copyright # 2010 John Wiley & Sons, Ltd. Pharmacoepidemiology and Drug Safety, 2010; 19: 825–833
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Table 5. Characteristics of the medication order associated with medication errors with and without patient harm after univariate logistic regression (odds
ratios) and multivariate logistic regression (adjusted odds ratios)
Medication errors without harm (substudy 1) Medication errors with harm (substudy 2)
Potential determinant Controls n (%) Cases n (%) OR 95% CI ORadj 95% CI Cases n (%) OR 95% CI ORadj 95% CI
Day of prescription (n¼ 8899/3398)
Monday 631 (19.1) 959 (17.1) ref ref 18 (17.8) ref
Tuesday 559 (17.0) 871 (15.5) 1.03 0.89–1.19 1.03 0.88–1.20 15 (14.9) 0.94 0.47–1.88
Wednesday 557 (16.9) 971 (17.3) 1.15 0.99–1.33 1.10 0.94–1.27 21 (20.8) 1.32 0.70–2.51
Thursday 530 (16.1) 951 (17.0) 1.18 1.02–1.37 1.08 0.93–1.26 20 (19.8) 1.32 0.70–2.53
Friday 587 (17.8) 1120 (20.0) 1.26 1.09–1.45 1.22 1.05–1.41 18 (17.8) 1.08 0.55–2.09
Saturday 203 (6.2) 352 (6.3) 1.14 0.93–1.40 1.28 1.04–1.57 7 (6.9) 1.21 0.50–2.94
Sunday 230 (7.0) 378 (6.7) 1.08 0.89–1.31 1.17 0.96–1.43 2 (2.0) 0.31 0.07–1.32
Weekend (weekdays
are reference)
433 (13.1) 730 (13.0) 0.99 0.87–1.13 9 (8.9) 0.65 0.32–1.29
Dosage frequency< once
daily
84 (2.5)x 163 (2.9) 1.16 0.89–1.52 1 (1.0)x 0.37 0.05–2.71
Route of administration
Oral 2346 (70.8) 3701 (65.8) ref ref 72 (70.6) ref
Topical 35 (1.1) 94 (1.7) 1.70 1.15–2.52 2.13y 0.99–4.62 1 (1.0) 0.93 0.13–6.89
Inhalation 66 (2.0) 209 (3.7) 2.01 1.52–2.66 1.17y 0.71–1.92 4 (3.9) 1.98 0.70–5.57
Dermal 19 (0.6) 123 (2.2) 4.10 2.52–6.67 3.31y 1.31–8.41 0 (0) z
Parenteral 758 (22.9) 1121 (19.9) 0.94 0.84–1.04 1.04y 0.91–1.18 23 (22.5) 0.99 0.61–1.59
Rectal 62 (1.9) 280 (5.0) 2.86 2.16–3.79 3.19y 2.33–4.37 2 (2.0) 1.05 0.25–4.38
Transdermal 29 (0.9) 55 (1.0) 1.20 0.76–1.89 0.91y 0.52–1.57 0 (0) z
Sublingual 0 (0) 39 (0.7) z z 0 (0) z
Figures in bold are statistically significant.
Abbreviations: OR, odds ratio; 95%CI, 95% confidence interval; ORadj, adjusted odds ratio ref, reference.Hospital, ward, length of stay, route of administration and pharmacotherapeutic area contributed significantly to the model.
yHospital, ward, transfer, length of stay, number of medication orders, day of prescription and pharmacotherapeutic area contributed significantly to the model.
zStatistical analysis not possible due to insufficient data.
xDummy variables included.
Table 6. Therapeutic areas associated with medication errors with and without patient harm after univariate logistic regression (odds ratios) and multivariate
logistic regression (adjusted odds ratios)
Medication errors without harm (substudy 1) Medication errors with harm (substudy 2)
Potential determinant Controls
n (%)
Cases n (%) OR 95% CI ORadj 95% CI Cases
n (%)
OR 95% CI ORadj 95% CI
Therapeutic area (ATC-code)
Gastrointestinal tract (A) 835 (25.2) 1166 (20.7) ref ref 20 (19.6) ref ref
Blood system (B) 478 (14.4) 691 (12.3) 1.04 0.89–1.20 1.13 0.95–1.33 14 (13.7) 1.22 0.61–2.44 1.22 0.60–2.45
Cardiovascular tract (C) 716 (21.6) 831 (14.8) 0.83 0.73–0.95 0.82 0.71–0.94 10 (9.8) 0.58 0.27–1.25 0.48 0.22–1.03
Dermatologicals (D) 24 (0.7) 124 (2.2) 3.70 2.37–5.78 1.45 0.59–3.53 0 (0) z z
Genitourinary system
and sex hormones (G)
40 (1.2) 35 (0.6) 0.63 0.40–1.00 0.59 0.36–0.96 1 (1.0) 1.04 0.14–7.97 0.84 0.11–6.51
Hormonal systemic therapy (H) 126 (3.8) 249 (4.4) 1.42 1.12–1.79 1.63 1.26–2.10 1 (1.0) 0.33 0.04–2.49 0.37 0.05–2.77
Anti-infectives (J) 264 (8.0) 454 (8.1) 1.23 1.03–1.47 1.28 1.06–1.56 23 (22.5) 3.64 1.97–6.73 4.20y 2.24–7.90
Cancer therapy (L) 47 (1.4) 47 (0.8) 0.72 0.47–1.08 0.81 0.49–1.35 0 (0) z z
Musculo-skeletal system (M) 86 (2.6) 172 (3.1) 1.43 1.09–1.89 1.62 1.20–2.20 2 (2.0) 0.97 0.22–4.22 1.08 0.25–4.75
Nervous system (N) 537 (16.2) 1415 (25.2) 1.89 1.65–2.16 1.85 1.60–2.14 25 (24.5) 1.94 1.07–3.53 1.62y 0.89–2.98
Anti-parasitic products,
insecticides and repellents (P)
13 (0.4) 5 (0.1) 0.28 0.10–0.78 0.40 0.14–1.18 0 (0) z z
Respiratory tract (R) 104 (3.1) 324 (5.8) 2.23 1.76–2.83 2.30 1.54–3.43 5 (4.9) 2.01 0.74–5.46 2.15 0.78–5.94
Sensory organs (S) 28 (0.8) 68 (1.2) 1.74 1.11–2.73 0.92 0.38–2.21 1 (1.0) 1.49 0.19–11.51 1.56 0.19–12.50
Various (V) 13 (0.4) 36 (0.6) 1.98 1.05–3.76 1.11 0.51–2.42 0 (0) z z
Unknown 4 (0.1) 5 (0.1) 0.90 0.24–3.34 1.02 0.23–4.59 0 (0) z z
Figures in bold are statistically significant.
Abbreviations: OR, odds ratio; 95%CI, 95% confidence interval; ORadj, adjusted odds ratio; ref, reference.Hospital, ward, transfer, length of stay, day of prescription and route of administration contributed significantly to the model.
yHospital, ward and age contributed significantly to the model.
zStatistical analysis not possible due to insufficient data.
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determinants for medication errors 831All other determinants that were statistically
significantly associated with medication errors without
harm (transfer of patient, length of hospital stay,
number of medication orders per patient, day of
prescription, route of administration and the other
therapeutic classes) showed no association with
medication errors with harm in the univariate analysis
already, had insufficient cases per category to analyse
the association or showed a different trend in the OR.
No determinants for medication errors leading to
harm were identified that had not been identified as
determinant for medication errors without harm.
DISCUSSION
This study is the first study on the comparison of
determinants for medication errors with and without
consequent patient harm. Hospital, ward and the
therapeutic class of anti-infectives were shown to be
determinants for both types of medication errors.
In this study relatively fewmedication errors causing
patient harm were identified, despite the collection of
more than 7000 medication orders during 5 months of
daily ward visits. This main limitation of our studymay
explain why many of the determinants that were
identified in the multivariate analysis for medication
errors without harm, were non-significant in the
univariate analysis for medication errors with harm.
The determinants hospital and ward point in the
same direction, namely that errors (either with or
without harm) probably occur more often in the TSh
than in the UMCG. Thus, even after correction for
case-mix, it remains likely that the personnel or local
processes influence the prevalence of errors, irrespec-
tive of the outcome.
Therefore, it may be concluded that for these
organisational determinants, medication errors are an
acceptable surrogate outcome measure for patient
harm. This corresponds with findings of previous
studies separately showing that organisational deter-
minants are linked to respectively medication errors
and pADEs.2,4,14,16,19,21
Differences between the two hospitals and wards
might be explained by differences in training of the
physicians.1,16,19,21,24,25 The UMCG is a university
tertiary care teaching hospital while the TSh is a
secondary care teaching hospital, where less education
may lead to more errors.
Due to the limited power of our study for medication
errors leading to harm, definite conclusions on
determinants that are more patient- or medication-
related cannot be drawn, with the possible exception of
anti-infectives. The association between anti-infectivesCopyright # 2010 John Wiley & Sons, Ltd.and errors might be explained by the fact that choosing
the right anti-infective for an infection could be more
difficult than choosing drugs for other indications.
Moreover, the dosage of most anti-infectives must be
adjusted according to the patient’s renal function, so
dosage errors are made more easily. Theoretically,
it seems likely that for medication errors leading to
patient harm, specific determinants may be identified
that reflect either the vulnerability of the patient to
experience pADEs or the intrinsic toxicity of the
medication. Anti-infectives, for example, have a great
intrinsic toxicity and are prescribed to acutely ill
patients, who are very susceptible for ADEs. This might
explain the association between anti-infectives and
pADEs.1–3,14,17,19,22,23 Again, the determinants ident-
ified in our study for medication errors without harm
were identified in other studies, both for medication
errors (identified determinants were number of medi-
cation orders per patient, route of administration and
pharmacotherapeutic area1,18,20) and for (preventable)
ADEs (identified determinants were among others
number of medication orders per patient and therapeutic
area1,14,17,19,20,22,23). However, none of these previous
studies compared the determinants for medication errors
without harm with the determinants for medication
errors leading to patient harm.
A number of explanations for identified associations
between specific determinants and the risk of
medication errors without harm can be given. First
of all, transfer of patients from home was associated
with medication errors without harm in this study.
Because no medication reconciliation was performed
at admission, errors can be made more easily when
patients are admitted from home, compared to transfers
between hospital wards or other affiliated care
institutions when actual medication is exchanged in
a specified way between health care professionals.
Prolonged length of stay increased the risk of a
medication error without harm. In the handwritten
system the medication orders have to be transcribed
again by nurses on a new administration chart when an
old chart is completed, which can cause transcribing
errors, which may explain this increased risk of
medication errors.
After correcting for confounding factors, an increas-
ing number of medication orders decreases the risk of
medication errors without harm slightly. This is not
consistent with previous studies and can possibly be
explained by extra attention of physicians to patients
who use more drugs.15 Medication orders prescribed
on Friday and Saturday were at risk for medication
errors without harm, which can be explained by a
higher workload and less knowledge about the patient’sPharmacoepidemiology and Drug Safety, 2010; 19: 825–833
DOI: 10.1002/pds
KEY POINTS
 Medication errors resulting in patient harm and
medication errors without patient harm have
some determinants in common.
 Common determinants were mainly at the
organisational level.
832 r. j. zaal ET AL.condition, because of staff changes and fewer
physicians being present.4,16,19,21 With dermal prep-
arations, directions for use, for example the site of
application, were often missing on the prescription.
This is an explanation for the high number of errors
without harm.18
For all of the determinants that were associated with
medication errors without harm, it can be suggested
that most of these errors were administrative errors
which result in patient harm less often than therapeutic
errors.5
Although most of the determinants identified in this
study cannot be influenced by health care professionals
directly to prevent patient harm, they give a first
impression of risk departments, risk processes and risk
medication and they are suitable to provide an answer
to the main study aim. However, future studies should
also focus on determinants that are more likely to be
influenced by health care professionals. Besides the
small sample size of medication errors leading to harm,
this study has several other limitations. First, only five
wards in two hospitals were studied, so the results
cannot be generalised to other medical specialties,
wards or hospitals. Second, the medication ordering
was done in the context of a handwritten system.
Implementation of a CPOE system with clinical
decision support could change the risk factors for
medication errors. Third, risk factors for medication
errors and consequent harm could differ between
continuation of pre-admission treatment and hospital-
initiated drugs. Because it was not necessary to define
pre-admission treatment in the POEMS study and
medication reconciliation was not performed, this
determinant could not be included in this study either.
However, prescribing errors and transcribing errors in
medication orders for continuation of pre-admission
treatment were assessed. Finally, only prescribing and
transcribing errors were considered in this study. To
provide a full overview of the potential determinants
for medication errors with and without harm distri-
bution errors, administration errors and ‘across
settings’ errors should also be studied.
The main strength of this study is the epidemiolo-
gical approach to identify risk factors by calculating
ORs, whereas many other studies used error frequen-
cies. Moreover, we established the actual outcome of
the medication error instead of the potential harm an
error could cause which many other studies did and our
study is the first comparing determinants for medi-
cation errors without and with patient harm.
Future research with a larger sample size of
medication errors leading to patient harm is recom-
mended. These future studies should also take intoCopyright # 2010 John Wiley & Sons, Ltd.account other types of medication errors and include
more organisational determinants (such as the use of
electronic prescribing) and patient related factors (like
the reason for admission and comorbidities).
CONCLUSION
To conclude, medication errors resulting in harm and
medication errors without harm have some determi-
nants in common, which are mainly at the organis-
ational level. Therefore, the present study gives a first
direction about the validity of medication errors as a
surrogate outcome measure when looking at these
organisational aspects. More determinants could
possibly be identified in studies with larger sample
sizes, which may identify specific patient- and
medication-related determinants for medication errors
leading to patient harm.
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